Overview Blood Products and Biospecimens
Blood products and biospecimens are essential components in medical research, diagnostics, and therapeutic development. From blood components like plasma and serum to isolated cells and tissue samples, each biospecimen offers information for studying physiological processes, understanding the mechanisms of diseases, and developing innovative treatments.
Researchers and clinicians utilize specimens to investigate biomarkers, conduct genetic analyses, explore immunological responses, and evaluate therapeutic interventions.
For diseased products and other sample types, visit our page: Other Biospecimens
What Research Donors can offer:
Right donor, right sample, right time!
Collecting, processing & delivering human blood products that meet your project needs
- Large and diverse donor pool (>3,500 registered and active donors) with comprehensive donor information provided
- High-quality materials to generate reliable data
- Meeting customer’s exact requirements for donor, biospecimen and protocol
- Selection of donor specifications such as age, sex, ethnicity, blood group, HLA type, etc
- Choice of anticoagulant, bags and vacutainer tubes, volume (large & regular supply – 9/10ml up to 490 ml)
- Serology screening prior to dispatch
- Chilled or ambient delivery temperature
- Delivery on the next day after collection
- Meeting regulatory and compliance needs (Collected at a UK HTA-licensed, ISO 9001 2015 certified facility, and cell storage license, ISO-9000)
- Ethics approval, donor consent, including for genetic analysis and commercial research purposes
Why work with us instead of collecting samples in-house?
- Expertise and specialization:
Outsourcing leukopak collection allows companies to leverage the specialized expertise of an external service provider. Research Donors ensures that samples are collected efficiently and according to industry best practices and ethical guidelines, reducing the risk of errors or contamination.
- Regulatory compliance:
Leukopak collection and handling are subject to strict regulatory requirements and quality standards, particularly when used in clinical trials or therapeutic applications. Outsourcing to Research Donors ensures compliance with these regulations, reducing the company's regulatory burden and risks.
- Cost savings:
Setting up and maintaining an in-house leukopak collection operation can be costly. Outsourcing eliminates the need for companies to invest in specialized equipment, trained personnel, and infrastructure. This can result in significant cost savings, especially for companies with infrequent or sporadic need for leukopaks.
- Scalability:
Outsourcing provides scalability. Companies can easily adjust the quantity of leukopaks collected to match their research or clinical trial requirements. This flexibility is advantageous as it avoids the fixed costs and resource constraints associated with maintaining an in-house collection operation.
- Focus on core competencies:
By outsourcing leukopak collection, companies can concentrate their resources and efforts on their core competencies, whether that's drug development, research, or therapeutic applications. This allows them to allocate more time and resources to activities that directly contribute to their mission and objectives.
- Mitigation of risk:
Outsourcing can help mitigate certain risks. Donor recruitment, collection procedures, and quality control can be complex and involve potential legal, ethical, and reputational risks. Research Donors has established protocols and experience in managing these risks.
- Access to diverse donor pools:
Research Donors has access to a large and diverse donor pool, which can be beneficial for research that requires specific demographics or a broader range of immune cell types. This can enhance the quality and relevance of the leukopaks collected.
- Time efficiency:
Outsourcing leukopak collection can expedite the process. Research Donors is experienced in handling collections efficiently, reducing the lead time between sample acquisition and research or clinical application.
- Reducing administrative burden:
The administrative tasks associated with donor recruitment, informed consent, and regulatory documentation can be time-consuming. Outsourcing these responsibilities can alleviate the administrative burden on the company.